Fundamental Analysis of Iradimed Co - Growth / Value Index


IRMD - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 17.19
   Price to Book Ratio of 7.53 suggesting that it is very expensive
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning 30.18 33.09 -20.89 %
Price to Book 7.61 7.57 3.86 % 7.11
Price to Sales 7.99 8.58 -14.78 %
Enterprise Value to EBITDA Multiple 23.30 30.32 2.43 %


IRMD - Profitability Highlights

Profitability Analysis

   Tremendous increasing trend in Net Profit for last 3 year
   Excellent Net Margin for last 3 years
   Company Earning excess return
   During the past twelve months, the company has given a strong Return On Equity of 25.21%
   During the past twelve months, the company has given a strong Return On Asset of 21.10%
   During the past twelve months, the company has given a strong Net Margin of 26.48%
   All key Trailing Twelve Months Margin growing by 15 %
   Piotroski F Score - Stable Value of 4.0
   EBITDA is continuously increasing for last 3 Years
   Good Return On Capital Employed of 22.86
   Low Earning Yield of 3.35 %
   EPS decline for last four quarters
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 25.21 22.86 31.29 % 5.43
Return On Asset 21.10 17.72 18.10 % 4.70
Net Profit Margin 26.48 25.93 7.73 % 23.51
Operating Profit Margin 30.70 30.38 3.61 % 26.98
EBITDA Margin 30.98 25.71 -15.29 % 28.07


Highlights
Market Cap537848 K
Enterprise Value488514 K
Price/Book TTM7.61
Outstanding Share12664.20 K
Float/ Outstanding Share56.55%
Dividend Yield1.42 %
Share Holding
Guru Numbers
Price/Graham No3.19
Peter Lynch Ratio0.876
Piotroski F Score4.00
Altman Z Score18.23
Sloan Ratio0.0405
Peter Lynch Fair Value24.30


IRMD - Growth Highlights

Growth Analysis

   Tremendous increasing trend in total sale last 3 year
   Quarterly sales in last 5 years is trending up
   Steady increase in Total Assets for last 3 Years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 67685.33 K 18.14 % 0.836 %
Gross Profit 51824.54 K 16.19 % 0.188 %
EBITDA 20967.85 K 0.079 % 4.27 %
Net Profit 17923.24 K 27.28 % 8.88 %
EPS 1.41 26.41 % NA


IRMD - Stability Highlights

Stability Analysis

   Tsr Stability Index - Excellent Score of 92.86
   Altman Z Score of 18.07 suggests good Stability
   Cash ratio of 3.05
   Interest Coverage of 0
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.0060 50.43 % 0.0055
Cash Ratio 3.05 -55.02 %
Quick Ratio 3.87 -54.55 % 7.77
Shareholders Equity 77.50 -10.04 %
Debt to EBITDA 0.0264 45.71 %


Historical Valuation Ratios of Iradimed Co

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Iradimed Co

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Iradimed Co

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Iradimed Co

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)